Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1α

Molecular and Cellular Biology

Volumn 24, Issue 12, 2004, Pages 5223-5234

  Wakisaka, Naohiro ^a,b   Kondo, Satoru ^a,b   Yoshizaki, Tomokazu ^b   Murono, Shigeyuki ^b   Furukawa, Mitsuru ^b   Pagano, Joseph S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOGENIC FACTOR; CATALASE; HELIX LOOP HELIX PROTEIN; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE P38; ONCOPROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; DNA BINDING; DNA RESPONSIVE ELEMENT; ENZYME INHIBITION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; EXTRACELLULAR FLUID; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION; VIRUS LATENCY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION; GENES, REPORTER; HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; HYDROGEN PEROXIDE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; NF-KAPPA B; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION; VIRAL MATRIX PROTEINS;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 2542443138     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.12.5223-5234.2004     Document Type: Article

References (72)

1. Agani, F., and G. L. Semenza. 1998. Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity. Mol. Pharmacol. 54:749-754.
2. Alvarez-Tejado, M., A. Alfranca, J. Aragones, A. Vara, M. O. Landazuri, and L. Peso. 2002. Lack of evidence for the involvement of the phosphoinositide 3-kinase/Akt pathway in the activation of hypoxia-inducible factors by low oxygen tension. J. Biol. Chem. 277:13508-13517.
3. Arsham, A. M., D. R. Plas, C. B. Thompson, and M. C. Simon. 2002. Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1α nor sufficient for HIF-1-dependent target gene transcription. J. Biol. Chem. 277:15162-15170.
4. Bonnet, M., J. M. Guinebretiere, E. Kremmer, V. Grunewald, E. Benhamou, G. Contesso, and I. Joab. 1999. Detection of Epstein-Barr virus in invasive breast cancers. J. Natl. Cancer Inst. 91:1376-1381.
5. Bruick, R. K., and S. L. McKnight. 2001. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294:1337-1340.
6. Carter, W. O., P. K. Narayanan, and J. P. Robinson. 1994. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J. Leukoc. Biol. 55:253-258.
7. Chandel, N. S., E. Maltepe, E. Goldwasser, C. E. Mathieu, M. C. Simon, and P. T. Schumacker. 1998. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 95:11715-11720.
8. Chandel, N. S., D. S. McClintock, C. E. Feliciano, T. M. Wood, J. A. Melendez, A. M. Rodriguez, and P. T. Schumacker. 2000. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1α during hypoxia: a mechanism of 02 sensing. J. Biol. Chem. 275:25130-25138.
9. Clerk, A., A. Michael, and P. H. Sugden. 1998. Stimulation of multiple mitogen-activated protein kinase subfamilies by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes. Biochem. J. 333:581-589.
10. Cobb, M. H., and E. J. Goldsmith. 1995. How MAP kinases are regulated. J. Biol. Chem. 270:14843-14846.
11. Dickens, M., J. S. Rogers, J. Cavanagh, A. Ratitano, Z. Xia, J. R. Halpern, M. E. Greenberg, C. L. Sawyers, and R. J. Davis. 1997. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277:693-696.
12. Elipoulos, A. G., N. J. Gallgher, S. M. S. Blake, C. W. Dawson, and L. S. Young. 1999. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J. Biol. Chem. 274:16085-16096.
13. Feldser, D., F. Agani, N. V. Iyer, B. Pak, B. Ferreira, and G. L. Semenza. 1999. Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2. Cancer Res. 59:3915-3918.
14. Fennewald, S., V. Santen, and E. Kieff. 1984. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J. Virol. 51:411-419.
15. Figueroa, Y. G., A. K. Chan, R. Ibrahim, Y. Tang, M. E. Burrow, J. Alam, and B. S. Scandurro. 2002. NF-κB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. Exp. Hematol. 30:1419-1427.
16. Fukuda, R., K. Hirota, F. Fan, Y. D. Jung, L. M. Ellis, and G. L. Semenza. 2002. Insulin-like growth factor 1 induces vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277:38205-38211.
17. 2 is mediated by hypoxia-inducible factor 1. Cancer Res. 63:2330-2334.
18. a. Hur, E., K. Y. Chang, S. Lee, and H. Park. 2001. Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not not the stabilization or DNA binding ability of hypoxia-inducible factor 1α. Mol. Pharmacol. 59:1216-1224.
19. Imai, S., J. Nishikawa, and K. Takada. 1998. Cell to cell contact as efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 72:4371-4378.
20. Izumi, K. M., and E. D. Kieff. 1997. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-KB. Proc. Natl. Acad. Sci. USA 94:12592-12597.
21. 2-regulated prolyl hydroxylation. Science 292:468-472.
22. Jackson, M. J., S. Papa, J. Bolanos, R. Bruckdorfer, H. Carlsen, R. M. Elliott, J. Flier, H. R. Griffiths, S. Heales, B. Holst, M. Lorusso, E. Lund, J. O. Moskaug, U. Moser, M. D. Paola, M. C. Polidori, A. Signorile, W. Stahl, J. Vina-Ribes, and S. B. Astley. 2002. Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function. Mol. Aspects Med. 23:209-285.
23. Jiang, B. H., F. Agani, A. Passaniti, and G. L. Semenza. 1997. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res. 57:5328-5335.
24. 2 tension. Am. J. Physiol. 271:C1172-C1180.
25. Jiang, B. H., J. Z. Zheng, M. Aoki, and P. K. Vogt. 2000. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc. Natl. Acad. Sci. USA 97:1749-1753.
26. Juang, Y. J., J. S. Isaacs, S. Lee, J. Trepel, and L. Neckers. 2003. IL-1β-mediated up-regulation of HIF-1α via an NFKB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 17:2115-2117.
27. Juang, Y. J., J. S. Isaacs, S. Lee, J. Trepel, and L. Neckers. 2002. Microtubule disruption utilizes an NFKB-dependent pathway to stabilize HIF-1α protein. J. Biol. Chem. 278:7445-7452.
28. Kallio, P. J., W. J. Wilson, S. O'Brien, Y. Makino, and L. Poellinger. 1999. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem. 274:6519-6525.
29. Kandel, E. S., and N. Hay. 1999. The regulation and activities of the multi-functional serine/threonine kinase Akt/PKB. Exp. Cell Res. 253:210-229.
30. Kieser, A., E. Kilger, O. Gires, M. Ueffing, W. Kolch, and W. Hammerschmidt. 1997. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J. 16:6478-6485.
31. Kimura, H., A. Weisz, Y. Kurashima, K. Hashimoto, T. Ogura, F. D'Acquisto, R. Addeo, M. Makuuchi, and H. Esumi. 2000. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95:189-197.
32. Krishnamachary, B., S. Berg-Dixon, B. Kelly, F. Agani, D. Feldser, G. Ferreira, N. Iyer, J. LaRusch, B. Pak, P. Taghavi, and G. L. Semenza. 2003. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63:1138-1143.
33. Laughner, E., P. Taghavi, K. Chiles, P. C. Mahon, and G. L. Semenza. 2001. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21:3995-4004.
34. Lee, Y. J., I. J. Kang, R. Bunger, and Y. H. Kang. 2004. Enhanced survival effect of pyruvate correlates MAPK and NF-κB activation in hydrogen peroxide-treated human endothelial cells. J. Appl. Physiol. 96:793-801.
35. Liu, X. H., A. Kirschenbaum, M. Lu, S. Yao, A. Dosoretz, J. F. Holland, and A. C. Levine. 2002. Prostaglandin E2 induces hypoxia-inducible factor-1α stabilization and nuclear localization in a human prostate cancer cell line. J. Biol. Chem. 277:50081-50086.
36. Maxwell, P. H., M. S. Wiesener, G. W. Chang, S. C. Clifford, E. C. Vaux, M. E. Cockman, C. C. Wykoff, C. W. Pugh, E. R. Maher, and P. J. Ratcliffe. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275.
37. Milanini, J., F. Vinals, J. Pouyssegur, and G. Pages. 1998. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J. Biol. Chem. 273:18165-18172.
38. Miller, W. E., H. S. Earp, and N. Raab-Traub. 1995. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J. Virol. 69:4390-4398.
39. Minet, E., G. Arnould, I. Michel, D. Roland, M. Mottet, J. Raes, R. Remacle, and C. Michels. 2000. ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett. 468:53-58.
40. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399.
41. Murono, S., H. Inoue, T. Tanabe, I. Joab, T. Yoshizaki, M. Furukawa, and J. S. Pagano. 2001. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc. Natl. Acad. Sci. USA 98:6905-6910.
42. Murono, S., T. Yoshizaki, H. Sato, M. Furukawa, and J. S. Pagano. 2000. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res. 60:3621-3626.
43. Narravula, S., and S. P. Colgan. 2001. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J. Immunol. 166:7543-7548.
44. Pagano, J. S. 1999. Epstein-Barr virus: the first human tumor virus and its role in cancer. Proc. Assoc. Am. Phys. 111:573-580.
45. Page, E. L., G. A. Robitaille, J. Pouyssegur, and D. E. Richard. 2002. Induction of hypoxia-inducible factor-1α by transcriptional and translational mechanisms. J. Biol. Chem. 277:48403-48409.
46. Richard, D. E., E. Berra, E. Gothie, D. Roux, and J. Pouyssegur. 1999. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 274:32631-32637.
47. Roberts, M. L., and N. R. Cooper. 1998. Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology 240:93-99.
48. Sandau, K. B., J. Zhou, T. Kietzmann, and B. Brune. 2001. Regulation of hypoxia-inducible factor 1α by the inflammatory mediators nitric oxide and tumor necrosis factor-α in contrast to desferroxamine and phenylarsine oxide. J. Biol. Chem. 276:39805-39811.
49. 2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15:551-578.
50. Semenza, G. L. 2000. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem. Pharmacol. 59:47-53.
51. Semenza, G. L. 2000. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 35:71-103.
52. 2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107:1-3.
53. Semenza, G. L. 2002. Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64:993-998.
54. Shimizu, N., H. Yoshiyama, and K. Takada. 1996. Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J. Virol. 70:7260-7263.
55. Sodhi, A., S. Montaner, V. Patel, M. Zohar, C. Bais, E. A. Mesri, and J. S. Gutkind. 2000. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α. Cancer Res. 60:4873-4880.
56. Sundaresan, M., Y. Zu-Xi, V. J. Ferrans, K. Irani, and T. Finkel. 1995. Requirement for generation of HO for platelet-derived growth factor signal transduction. Science 270:296-299.
57. Sutter, C. H., E. Laughner, and G. L. Semenza. 2000. Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc. Natl. Acad. Sci. USA 97:4748-4753.
58. Suzuki, Y. J., H. J. Forman, and A. Sevanian. 1997. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22:269-285.
59. Takimoto, T., M. Furukawa, M. Hatano, and R. Umeda. 1984. Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells. Ann. Otol. Rhinol. Laryngol. 93:166-169.
60. Ushio-Fukai, M., R. W. Alexander, M. Akers, and K. K. Griendling. 1998. p38 MAP kinase is a critical component of the redox-sensitive signaling pathways by angiotensin II: role in vascular smooth muscle cell hypertrophy. J. Biol. Chem. 273:15022-15029.
61. Wakisaka, N., S. Murono, T. Yoshizaki, M. Furukawa, and J. S. Pagano. 2002. Epstein-Barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2. Cancer Res. 62:6337-6344.
62. Wang, D., D. Liebowitz, and E. Kieff. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
63. 2 tension. Proc. Natl. Acad. Sci. USA 92:5510-5514.
64. Welsh, S. J., W. T. Bellamy, M. M. Briehl, and G. Powis. 2002. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1α protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 62:5089-5095.
65. Yen, C. H., C. C. Hsieh, S. Y. Chou, and Y. T. Lau. 2001. 17β-Estradiol inhibits oxidized low density lipoprotein-induced generation of reactive oxygen species in endothelial cells. Life Sci. 70:403-413.
66. Yoshizaki, T., T. Horikawa, R. Qing-chun, N. Wakisaka, H. Takeshita, T. S. Sheen, S. Y. Lee, H. Sato, and M. Furukawa. 2001. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma. Clin. Cancer Res. 7:1946-1951.
67. Yoshizaki, T., H. Sato, M. Furukawa, and J. S. Pagano. 1998. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc. Natl. Acad. Sci. USA 95:3621-3626.
68. Yu, F., S. B. White, Q. Zhao, and F. S. Lee. 2001. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98:9630-9635.
69. Zhang, J., N. Jin, Y. Liu, and R. A. Rhoades. 1998. Hydrogen peroxide stimulates signal-regulated protein kinases in pulmonary arterial smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 19:324-332.
70. Zhang, L., and J. S. Pagano. 1999. Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency. Mol. Cell. Biol. 19:3216-3223.
71. Zhong, H., D. Chiles, D. Feldser, E. Laughner, C. Hanrahan, M. M. Georgescu, J. W. Simons, and G. L. Semenza. 2000. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidyl-inositol-3 kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60:1541-1545.
72. Zundel, W., C. Schindler, D. Haas-Kogan, A. Koong, F. Kaper, E. Chen, A. R. Gottschalk, H. E. Ryan, R. S. Johnson, A. B. Jefferson, D. Stokoe, and A. J. Giaccia. 2000. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14:391-396.